A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency

Recruiting Observational Study
Premature Ovarian Insufficiency
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
10 – 65
Sex
Female
Study type
Observational
Participants needed
1,080 (estimated)
Sponsor
Women's Hospital School Of Medicine Zhejiang University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Premature ovarian insufficiency (POI) refers to the occurrence of ovarian hypofunction in women before the age of 40, which seriously affects women's overall health and quality of life. However, there is currently insufficient understanding of the risk factors, pathogenesis, short-term and long-term health effects of POI, and the health effects of the disease, and there is a lack of high-quality e…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Women with POI 1. Inclusion Criteria 1.1 Age at Diagnosis: Less than 40 years of age. 1.2 Diagnosis of POI: Met one of the following diagnostic criteria based on ESHRE guidelines: Spontaneous POI: Oligomenorrhea or amenorrhea for at least 4 months, combined with elevated FSH levels (\> 25 IU/L) on …
Contacts

Jianhong Zhou, Doctor of Medicine(M.D.)

86 15990008569

zhoujh1117@zju.edu.cn

CONTACT